Abstract
In acquired brain injury (ABI), including both CVA(cerebrovascular accident) and TBI (traumatic brain injury) there can be profound effects on the genitourinary tract. A spectrum of voiding disorders may range from urinary retention to complex incontinence. Often, normal urinary or sexual changes are seen with aging, yet comorbid conditions are frequently present in the elderly that may complicate and predate CVA or TBI.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Amundsen, C.L., Webster, G.D. (2002) Sacral neuromodulation in an older, urge incontinent population. American Journal of Obstetrics and Gynecology 187:1462–1465.
Appell, R.A., Chancellor, M.B., Zobrist, R.H., Thomas H., Sanders, S.W. (2003) Pharmacokinetics, metabolism and saliva output during transdermal and extended release oral oxybutynin administration in healthy subjects. Mayo Clinical Proceedings 78:696–702.
Borrie, M.J., Campbell, A.J., Caradoc-Davies, T.H., Spears, G.F. (1985) Urinary incontinence after stroke: A prospective study. Age Ageing 15:177–181.
Bosch, J.L.H.R. (1998) Sacral neuromodulation in the treatment of the unstable bladder. Current Opinion in Urology. 8:287–291.
Brockelhurst, J.C., Andrews, K., Richards, B., Laycock, P.J. (1985) Incidence and correlates of incontinence in stroke patients. Journal of the American Geriatrics Society 33:540–542.
Burney, T.L., Senapati, M., Desai, S., Choudhary, ST., Badlani, G.H. (1996) Acute cerebrovascular accident and lower urinary tract dysfunction: A prospective correlation of the site of brain injury with urodynamic findings. The Journal of Urology 156:1748.
Davila, G.W., Daugherty, C.A., Sanders, S.W. (2001) A short term, multicenter, randomized double-blind dose titration study of the efficacy and anticholinergic side effects of transdermal oxybutynin compared to immediate release oral oxybutynin treatment of patients with urge urinary incontinence. The Journal of Urology 166:140–145.
Dmochowski, R.R., Davila, G.W., Zinner, N.R., Gittelman, M.C., Saltzstein, D.R., Lyttle, S., Sanders, S.W. (2002) Efficacy and safety of transdermal oxybutynin in patients with urge and mixed incontinence. The Journal of Urology 168:580–586.
Dmochowski, R.R., Sand, P.K., Zinner, N.R., Gittelman, M.C., Davila, G.W., Sanders, S.W. (2003) Comparative efficacy and safety of transdermal oxybutynin and oral tolterodine versus placebo in previously treated patients with urge and mixed urinary incontinence. Urology 62:237–242.
Flynn, M.K., Webster, G.D., Amundsen, C.L. (2004) The effect of botulinum-a toxin on patients with severe urge urinary incontinence. The Journal of Urology 172:2316–2320.
Gelber, D.A., Good, D.C., Laven, L.J., Verhulst, S.J. (1993) Cause of urinary incontinence after acute hemispheric stroke. Stroke 24:378–382.
Giannitsas, K., Perimenis, P., Athanasopoulos, A., Gyftopoulos, K., Nikiforidis, G., Barbalias, G. (2004) Comparison of efficacy of tolterodine and oxybutynin in different urodynamic severity grades of idiopathic detrusor overactivity. European Urology 46:776–782.
Gjone, R. (1966) Excitatory and inhibitory bladder response to stimulation of limbic, diencephalic and mesencephalic structures in the cat. Acta physiologica Scandinavica 66: 91–102.
Katz, G.P., Blaivas, J. (1983) A diagnostic dilemma: When urodynamic findings differ from the clinical impression. The Journal of Urology 129:1170–4, 1983
Korpelainen, J.T., Neiminen, P., Myllyla, V.V. (1999) Sexual functioning among stroke patients and their spouses. Stroke 30:715–719.
Lum, S.K., Marshall, V.R. (1982) Results of prostatectomy in patients following a cerebrovascular accident. British Journal of Urology 54:186.
Lundberg, P.O., Ertekin, C., Ghezzi, A. (2001) Neurosexology: Guidelines for neurologists. European Journal of Neurology 8(Suppl 3):2–24.
Marincovic, S., Badlani, G. (2001) Voiding and sexual dysfunction after cerebrovascular accidents. The Journal of Urology 165:359–370.
Masters, W.H., Johnson, V.E. (1966) Human Sexual Response. Boston: Little Brown & Co.
McKeage, K., Plosker, G.L. (2002) Alfuzosin: A review of the therapeutic use of the prolonged-release formulation given once daily in the management of benign prostatic hyperplasia. Drugs 62:633–653.
Nakayama, H., Jorgensen, H.S., Pedersen, P.M., Raaschou, H.O., Olsen, T.S. (1997) Prevalence and risk factors of incontinence after stroke: The Copenhagen stroke study. Stroke28:58–62.
Nitti, V. W., Adler, H., Combs, A. J. (2003) The role of urodynamics in the evaluation of voiding dysfunction in men after Cerebrovascular accident. The Journal of Urology 155:263–266.
Pak, R.W., Petrou, S.P., Staskin, D.R. (2003) Trospium chloride: A quarternary amine with unique pharmacologie properties. Current Urology Reports 4(6):436–440.
Patel, M., Coshall, C., Lawrence, E. (2001) Recovery from poststroke urinary incontinence: Associated factors and impact on outcome. Journal of the American Geriatrics Society 49:1229–1233.
Pickard, R., Reaper, J., Wyness, L., Cody, D. J., McClinton, S., N'Dow, J. (2003) Periurethral injection therapy for urinary incontinence in women. Cochrane Database Systematic Reviews (2):CD003881, 2003.
Rackley, R., Abdelmalak, J. (2004) Urologie applications of Botulinum toxin therapy for voiding dysfunction. Current Urology Reports 5:381–388.
Resnick, N.M., Yalla, S.V. (1985) Management of urinary incontinence in the elderly. New England Journal of Medicine 313(13):800–805.
Sakakibara, R., Shinotoh, H., Uchiyama, T., Sakuma, M., Kashiwado, M., Yoshiyama, M., Hattori, T. (2001) Questionnaire-based assessment of pelvic organ dysfunction in Parkinson's disease. Autonomie Neuroscience: Basic & Clinical 92:76–85.
Seki, S., Igawa, Y., Kaidoh, K. (2001) Role of dopamine D1 and D2 receptors in the micturition reflex in conscious rat. Neurourology and Urodynamics 20:105–113.
Siroky, M. (2003) Neurological disorders: Cerebrovascular disease and Parkinsonism. The Urologie Clinics of North America 30:27–47.
Taub, N.A., Wolfe, C.D., Richardson, E., Burney, P.G. (1994) Predicting the disability of first-time stroke sufferers at 1 year. 12 month follow up of a population-based cohort in southeast England. Stroke 25:352.
Yokoyama, O., Komatsu, K., Ishiura, Y. (1998) Change in bladder contractility associated with bladder overactivity in rats with cerebral infraction. The Journal of Urology 159:577–580.
Yokoyama, O., Yoshiyama, Y, Namiki, M., de Groat, W.C. (1999) Glutamatergic and dopaminergic contributions to rat bladder hyperactivity after cerebral artery occlusion. The American Journal of Physiology 276:R935–R942.
Wyndaele, J.J. (1993) Muscular weakness as side effect of Botulinum toxin injection for neurogenic detrusor overactivity. Spinal Cord 40:599–560.
Zinner, N., Gittelman, M., Harris, R., Susset, J., Kanelos, A., Auerbach, S. (2004) Trospium chloride improves overactive bladder symptoms: a multicenter phase III trial. The Journal of Urology 171(6 Pt 1):2311–2315.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2007 Springer
About this chapter
Cite this chapter
KARLOVSKY, M.E., BADLANI, G.H. (2007). Voiding and Sexual Dysfunction after Acquired Brain Injury. In: Elbaum, J., Benson, D.M. (eds) Acquired Brain Injury. Springer, New York, NY. https://doi.org/10.1007/978-0-387-37575-5_5
Download citation
DOI: https://doi.org/10.1007/978-0-387-37575-5_5
Publisher Name: Springer, New York, NY
Print ISBN: 978-0-387-37574-8
Online ISBN: 978-0-387-37575-5
eBook Packages: Behavioral ScienceBehavioral Science and Psychology (R0)